ConductScience.org, home

Paper38829482

Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B.

Noor S and 8 others. Mol Cell Biochem, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B. Papers, record 38829482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38829482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B.
PubMed
Journal
Mol Cell Biochem
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-11-02
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Noor SSaba
2Choudhury AArunabh
3Islam KUKhursheed Ul
4Yousuf MMohd
5Raza AAli
6Ansari MAMohammad Ahmad
7Ashraf AAnam
8Hussain AAfzal
9Hassan MIMd Imtaiyaz

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aurora Kinase BMajor topic
NoscapineMajor topic
Lung NeoplasmsMajor topic
Neoplasm ProteinsMajor topic
Protein Kinase InhibitorsMajor topic
Humans
A549 Cells
Molecular Docking Simulation

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R.12014/60/2022-HRIndian Council of Medical ResearchPubMed
Researchers Supporting Project Number (RSPD2024R980)King Saud UniversityPubMed

Source PubMed

Download CSV of grants

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128830777Biological evaluation of p-toluene sulphonylhydrazone as carbonic anhydrase IX inhibitors: An approach to fight hypoxia-induced tumors.Int J Biol Macromol2018https://conductscience.org/library/papers/28830777PubMed
221423660Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.PLoS One2011https://conductscience.org/library/papers/21423660PubMed
327496133Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.Mol Cancer Ther2016https://conductscience.org/library/papers/27496133PubMed
417893514Apoptotic pathway induced by noscapine in human myelogenous leukemic cells.Anticancer Drugs2007https://conductscience.org/library/papers/17893514PubMed
537141737Biochemical features and therapeutic potential of α-Mangostin: Mechanism of action, medicinal values, and health benefits.Biomed Pharmacother2023https://conductscience.org/library/papers/37141737PubMed
632422877Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy.Biomedicines2020https://conductscience.org/library/papers/32422877PubMed
726638998Aurora-B and HDAC synergistically regulate survival and proliferation of lymphoma cell via AKT, mTOR and Notch pathways.Eur J Pharmacol2016https://conductscience.org/library/papers/26638998PubMed
836851679Global Lipidome Profiling Revealed Multifaceted Role of Lipid Species in Hepatitis C Virus Replication, Assembly, and Host Antiviral Response.Viruses2023https://conductscience.org/library/papers/36851679PubMed
931343173Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4.J Nat Prod2019https://conductscience.org/library/papers/31343173PubMed
1034445523Aurora B Tension Sensing Mechanisms in the Kinetochore Ensure Accurate Chromosome Segregation.Int J Mol Sci2021https://conductscience.org/library/papers/34445523PubMed
1119626589Non-toxic melanoma therapy by a novel tubulin-binding agent.Int J Cancer2010https://conductscience.org/library/papers/19626589PubMed
1218032922VX-680 inhibits Aurora A and Aurora B kinase activity in human cells.Cell Cycle2007https://conductscience.org/library/papers/18032922PubMed
1334054126Small molecules in targeted cancer therapy: advances, challenges, and future perspectives.Signal Transduct Target Ther2021https://conductscience.org/library/papers/34054126PubMed
1424057926Thymol inhibits LPS-stimulated inflammatory response via down-regulation of NF-κB and MAPK signaling pathways in mouse mammary epithelial cells.Inflammation2014https://conductscience.org/library/papers/24057926PubMed
1531273958Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway.Cancer Med2019https://conductscience.org/library/papers/31273958PubMed
1630259761A comprehensive review of protein kinase inhibitors for cancer therapy.Expert Rev Anticancer Ther2018https://conductscience.org/library/papers/30259761PubMed
1734448628Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase.OMICS2021https://conductscience.org/library/papers/34448628PubMed
1827285995Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.PLoS One2016https://conductscience.org/library/papers/27285995PubMed
1932905276Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer.ACS Omega2020https://conductscience.org/library/papers/32905276PubMed
2034303039Identification of novel anti-cancer agents by the synthesis and cellular screening of a noscapine-based library.Bioorg Chem2021https://conductscience.org/library/papers/34303039PubMed

See all 54 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42415924ZnO@PDA@Ag nanocomposite-mediated delivery of 9-bromonoscapine, an anticancer agent, for enhanced lung cancer therapy.Nanoscale Adv2026https://conductscience.org/library/papers/42415924PubMed
40453822Exploring anticancer activity of baicalin, naringenin, and noscapine via binding and inhibition of sphingosine kinase 1.3 Biotech2025https://conductscience.org/library/papers/40453822PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AURKB9212PubTator's text mininghttps://conductscience.org/library/genes/9212

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38829482

GET https://conductscience.org/api/papers/v1/38829482/references?page=2